Nanotechnology application for pain therapy
Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of these agents to target sites with a reduced level of systemic toxicity. Different analgesics have been loaded...
Gespeichert in:
Veröffentlicht in: | Artificial cells, nanomedicine, and biotechnology nanomedicine, and biotechnology, 2018-03, Vol.46 (2), p.368-373 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 373 |
---|---|
container_issue | 2 |
container_start_page | 368 |
container_title | Artificial cells, nanomedicine, and biotechnology |
container_volume | 46 |
creator | Moradkhani, Mahmoud Reza Karimi, Arash Negahdari, Babak |
description | Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of these agents to target sites with a reduced level of systemic toxicity. Different analgesics have been loaded onto various nano carriers, including those that are natural, synthetic and copolymer, for various medical applications. In this review, we will discuss the concept of nano-formulated carriers for analgesic drugs and their impacts on the field of pain management. |
doi_str_mv | 10.1080/21691401.2017.1313265 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_21691401_2017_1313265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1999178875</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-1b62233ba1fc8d7c4314a810036f763e4e429288c9e310fd4e992c1491e488ba3</originalsourceid><addsrcrecordid>eNp9kFtLwzAUx4Mobsx9BKXgo3TmJGmavCljXmDoi4JvIU0T19E1NemQfns7dnn0vJzD4X-BH0LXgGeABb4nwCUwDDOCIZ8BBUp4dobGu38KDL7OTzeGEZrGuMbDCOB5xi7RiAgqswz4GN296cZ31qwaX_vvPtFtW1dGd5VvEudD0uqqSbqVDbrtr9CF03W008OeoM-nxcf8JV2-P7_OH5epYQy6FApOCKWFBmdEmRtGgWkBGFPuck4ts4xIIoSRlgJ2JbNSEgNMgmVCFJpO0O0-tw3-Z2tjp9Z-G5qhUoGUEnIh8mxQZXuVCT7GYJ1qQ7XRoVeA1Y6SOlJSO0rqQGnw3RzSt8XGlifXkckgeNgLqmYgsNG_PtSl6nRf--CCbkwVFf2_4w9agHPc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1999178875</pqid></control><display><type>article</type><title>Nanotechnology application for pain therapy</title><source>Alma/SFX Local Collection</source><creator>Moradkhani, Mahmoud Reza ; Karimi, Arash ; Negahdari, Babak</creator><creatorcontrib>Moradkhani, Mahmoud Reza ; Karimi, Arash ; Negahdari, Babak</creatorcontrib><description>Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of these agents to target sites with a reduced level of systemic toxicity. Different analgesics have been loaded onto various nano carriers, including those that are natural, synthetic and copolymer, for various medical applications. In this review, we will discuss the concept of nano-formulated carriers for analgesic drugs and their impacts on the field of pain management.</description><identifier>ISSN: 2169-1401</identifier><identifier>EISSN: 2169-141X</identifier><identifier>DOI: 10.1080/21691401.2017.1313265</identifier><identifier>PMID: 28395516</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Analgesic drugs ; Analgesics ; Drug delivery ; Drug delivery systems ; nano-carriers ; Nanotechnology ; Pain ; Pain management ; Toxicity</subject><ispartof>Artificial cells, nanomedicine, and biotechnology, 2018-03, Vol.46 (2), p.368-373</ispartof><rights>2017 Informa UK Limited, trading as Taylor & Francis Group 2017</rights><rights>2017 Informa UK Limited, trading as Taylor & Francis Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-1b62233ba1fc8d7c4314a810036f763e4e429288c9e310fd4e992c1491e488ba3</citedby><cites>FETCH-LOGICAL-c441t-1b62233ba1fc8d7c4314a810036f763e4e429288c9e310fd4e992c1491e488ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28395516$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moradkhani, Mahmoud Reza</creatorcontrib><creatorcontrib>Karimi, Arash</creatorcontrib><creatorcontrib>Negahdari, Babak</creatorcontrib><title>Nanotechnology application for pain therapy</title><title>Artificial cells, nanomedicine, and biotechnology</title><addtitle>Artif Cells Nanomed Biotechnol</addtitle><description>Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of these agents to target sites with a reduced level of systemic toxicity. Different analgesics have been loaded onto various nano carriers, including those that are natural, synthetic and copolymer, for various medical applications. In this review, we will discuss the concept of nano-formulated carriers for analgesic drugs and their impacts on the field of pain management.</description><subject>Analgesic drugs</subject><subject>Analgesics</subject><subject>Drug delivery</subject><subject>Drug delivery systems</subject><subject>nano-carriers</subject><subject>Nanotechnology</subject><subject>Pain</subject><subject>Pain management</subject><subject>Toxicity</subject><issn>2169-1401</issn><issn>2169-141X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kFtLwzAUx4Mobsx9BKXgo3TmJGmavCljXmDoi4JvIU0T19E1NemQfns7dnn0vJzD4X-BH0LXgGeABb4nwCUwDDOCIZ8BBUp4dobGu38KDL7OTzeGEZrGuMbDCOB5xi7RiAgqswz4GN296cZ31qwaX_vvPtFtW1dGd5VvEudD0uqqSbqVDbrtr9CF03W008OeoM-nxcf8JV2-P7_OH5epYQy6FApOCKWFBmdEmRtGgWkBGFPuck4ts4xIIoSRlgJ2JbNSEgNMgmVCFJpO0O0-tw3-Z2tjp9Z-G5qhUoGUEnIh8mxQZXuVCT7GYJ1qQ7XRoVeA1Y6SOlJSO0rqQGnw3RzSt8XGlifXkckgeNgLqmYgsNG_PtSl6nRf--CCbkwVFf2_4w9agHPc</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Moradkhani, Mahmoud Reza</creator><creator>Karimi, Arash</creator><creator>Negahdari, Babak</creator><general>Taylor & Francis</general><general>Taylor & Francis Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201803</creationdate><title>Nanotechnology application for pain therapy</title><author>Moradkhani, Mahmoud Reza ; Karimi, Arash ; Negahdari, Babak</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-1b62233ba1fc8d7c4314a810036f763e4e429288c9e310fd4e992c1491e488ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Analgesic drugs</topic><topic>Analgesics</topic><topic>Drug delivery</topic><topic>Drug delivery systems</topic><topic>nano-carriers</topic><topic>Nanotechnology</topic><topic>Pain</topic><topic>Pain management</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moradkhani, Mahmoud Reza</creatorcontrib><creatorcontrib>Karimi, Arash</creatorcontrib><creatorcontrib>Negahdari, Babak</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Artificial cells, nanomedicine, and biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moradkhani, Mahmoud Reza</au><au>Karimi, Arash</au><au>Negahdari, Babak</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nanotechnology application for pain therapy</atitle><jtitle>Artificial cells, nanomedicine, and biotechnology</jtitle><addtitle>Artif Cells Nanomed Biotechnol</addtitle><date>2018-03</date><risdate>2018</risdate><volume>46</volume><issue>2</issue><spage>368</spage><epage>373</epage><pages>368-373</pages><issn>2169-1401</issn><eissn>2169-141X</eissn><abstract>Prolonged delivery of analgesic drugs at target sites remains a critical issue for efficient pain management. The use of nano-carriers has been reported to facilitate applicable delivery of these agents to target sites with a reduced level of systemic toxicity. Different analgesics have been loaded onto various nano carriers, including those that are natural, synthetic and copolymer, for various medical applications. In this review, we will discuss the concept of nano-formulated carriers for analgesic drugs and their impacts on the field of pain management.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>28395516</pmid><doi>10.1080/21691401.2017.1313265</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2169-1401 |
ispartof | Artificial cells, nanomedicine, and biotechnology, 2018-03, Vol.46 (2), p.368-373 |
issn | 2169-1401 2169-141X |
language | eng |
recordid | cdi_crossref_primary_10_1080_21691401_2017_1313265 |
source | Alma/SFX Local Collection |
subjects | Analgesic drugs Analgesics Drug delivery Drug delivery systems nano-carriers Nanotechnology Pain Pain management Toxicity |
title | Nanotechnology application for pain therapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T19%3A39%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nanotechnology%20application%20for%20pain%20therapy&rft.jtitle=Artificial%20cells,%20nanomedicine,%20and%20biotechnology&rft.au=Moradkhani,%20Mahmoud%20Reza&rft.date=2018-03&rft.volume=46&rft.issue=2&rft.spage=368&rft.epage=373&rft.pages=368-373&rft.issn=2169-1401&rft.eissn=2169-141X&rft_id=info:doi/10.1080/21691401.2017.1313265&rft_dat=%3Cproquest_cross%3E1999178875%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1999178875&rft_id=info:pmid/28395516&rfr_iscdi=true |